Adam Torres and Marcy Rogers discuss the launch of PreV Pro cream.

Subscribe: iTunes / Spotify / Stitcher / RSS

Apply to be a guest on our podcast here.

Show Notes:

What if there was a way to mitigate the risk of getting a concussion while playing sports? In this episode, Adam Torres and Marcy Rogers, President and CEO at SpineMark, explore how PreV Pro cream intends on helping athletes mitigate the risk of getting a concussion during physical activity.

About SpineMark

SpineMark Corporation is an innovative service organization dedicated to transforming the delivery of  care and innovation. The company partners with hospitals and physicians across the United States and globally to develop and operate comprehensive, evidence-based spine centers of excellence.  By building a global network of spine centers, spine research organizations and state-of-the-art medical conference facilities, SpineMark is improving the overall quality of life of patients afflicted with spine disorders and injuries. 

Driven by the specialized experience and expertise of its leadership team and Medical Advisory Board, SpineMark maintains high standards for spine care in its global network, creating clinically validated best practices for spine care that streamline diagnosis and treatment, simplify referrals and accelerate the recovery process.

Apply to be a guest on our podcast here

Get the Mission Matters News FREE here

Share.
Adam Torres

Adam Torres is Host of the Mission Matters series of shows, ranked in the top 5% out of 3,268,702 podcasts globally. As Co-Founder of Mission Matters, a media, PR, marketing and book publishing agency, Adam is dedicated to amplifying the voices of entrepreneurs, entertainers, executives and experts. An international speaker and author of multiple books on business and investing, his advice is featured regularly in major media outlets such as Forbes, Yahoo! Finance, Fox Business, and CBS to name a few.

Please ensure Javascript is enabled for purposes of website accessibility
×

Thank You for Subscribing.